Table 2.
Protocol A | Protocol B | P- value | |
---|---|---|---|
Age (months) | 7.3 ± 4.8 [2–24] | 8.1 ± 7.3 [0-35] | 0.626 |
Gender (male/female) | 15/9 (62.5 %/37.5 %) | 17/7 (71 %/29 %) | 0.759 |
DFOV (mm) | 175 ± 23 (171) | 177 ± 24 (179) | 0.779 |
CTDIvol (mGy) | 32.18 ± 0.04 (32.19) | 0.94 ± 0.01 (0.93) | <0.001* |
DLP (mGy*cm) | 487.48 ± 33.14 (486.70) | 15.04 ± 2.25 (14.28) | <0.001* |
Effective dose (mSv) | 3.07 ± 0.16 (3.13) | 0.08 ± 0.00 (0.08) | <0.001* |